deficit in the MLR that was associated with reduced IL-2 secretion and normal IL-2-R expression (Bass, H., and S. Strober, manuscript submitted for publication) .
The results of the present study using TLI-treated BALB/c mice indicate that there are two or more functionally distinct mouse CD4 subsets in vivo. One subset of cells (Thl-like) secretes IL-2 and/or IFN-y and contributes to cell-mediated immunity. The function of these cells recovers slowly after TLI (at -3 mo) to the pretreatment levels . Another subset ofcells (Th2-like) secretes IL-4 and/or IL-5 and plays a critical role in humoral immunity. The latter cells return more rapidly (at N4-6 wk) after the irradiation . This results in a transient change in the proportion of these two subsets in the spleens of TLI-treated mice, such that Thl-like cells are selectively reduced after irradiation .
Materials and Methods
Animals . BALB/c (H -2d), C57BL/Ka (H-2 b), and C3H/Km (H-2k) mice were obtained from the specific pathogen-free colony in the Department of Radiology, Stanford University Medical School. During administration of irradiation, BALB/c mice were housed in conventional animal rooms. Tetracycline (0.5 jig/ml) was added to the drinking water during the 3 wk of TLI treatment . CBA/J (H-2Ik) mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and were housed in the Stanford Medical Center animal facility.
TLI. 4-6-mo-old male BALB/c mice were placed in an apparatus designed to irradiate the major lymphoid organs, including all major lymph nodes, spleen, and thymus, as previously described (18) . The mice were given 250 rad/d, five times per week, for a total dose of4,250 rad in 17 treatments . TLI was delivered from a single 250-Kv (15 A) source (Phillips Medical System Inc., Shelton, CT) .
Whole Body Irradiation (WBI). The mice were placed in lucite containers and given a sublethal dose of 550 rad, or a lethal dose of 850-rad irradiation. WBI was delivered from a single 250-Kv (15 A) source (Phillips Medical System Inc.). The dose rate was 93 rad/min, using a 0.35-mm Cu filter at a 52-cm source-axis distance.
Preparation ofCells. Spleens were removed aseptically and a single cell suspension was prepared by gently pressing the spleen through a nylon fiber mesh (Tetko Inc., Elmsford, NY) .
Immunofluorescent Staining and Analysis Using the FACS . The rat anti-mouse mAbs used for immunofluorescent staining included antiThy-1 .2 (clone 30-H12, IgG2a; American Type Culture Collection [ATCC], Rockville, MD), anti-IgM (11B5, IgGI ; gift of Dr. I. Weissman, Stanford University), anti-CD8 (Lyt-2 in mouse, clone 53-6.76, IgG2a; ATCC), anti-CD4 (L3T4 in mouse, GK 1.5, IgG2b; Becton Dickinson & Co., Mountain View, CA) . Hamster anti-mouse IL-2-R mAb (M7/20) (IgM), was obtained from Dr. V. Kelley, Harvard University, Cambridge, MA. Fluoresceinated goat anti-rat Ig used as the second-stage antibody was purchased from Boehringer Mannheim Biochemicals (Indianapolis, IN) . Phycoerythrinconjugated anti-CD8 and CD4 antibodies were also obtained from Becton Dickinson & Co. A rat anti-mouse idiotype mAb was used as an irrelevant control for staining with rat-derived antibodies (Dr. R. Levy, Stanford University). The concentration of the staining reagents corresponded to their saturation points on the standard dilution curves.
Immunofluorescent staining procedures were as described previously (29) . The stained cells were analyzed on a FACS II (Becton Dickinson & Co.). The negative controls contained cells stained with an irrelevant first-stage antibody. The percentage of positive cells was determined by thresholdsdescribed previously (29) . Approximately 2-3 % ofthe cells stained with irrelevant antibody were positive at this threshold point.
Purification of Ig* Cells. A technique similar to that of Wysocki and Sato (32) was used. Petri dishes were coated with affinity-purified goat anti-rat IgG (Boehringer Mannheim Biochemicals) at 4°C for 10-12 h. Ammonium chloride potassium-treated spleen cells were first incubated on ice with rat anti-mouse Thy-1 .2 mAb (clone 30-H12 ; Becton Dickinson & Co.) for 30 min. The cells were then washed and added to the coated petri dishes . 1 h later, the nonadherent cells were collected, washed, and resuspended in PBS.
After each panning procedure, the negatively selected cells were stained with rat antiThy-1.2 mAb (see above) or monoclonal rat anti-IgM (11B5), and analyzed on a FACS in order to check the purity of the cells. The Ig' cells were enriched from a mean of 45 .2% of the total spleen cells to a mean of81.8% ofthe transferred "panned" cells . The mean contamination of the Thy-1 .2' cells after panning for B cells was 2.2%.
Purification of CD4' Cells. To purify CD4' cells, petri dishes were coated with affinitypurified goat anti-mouse IgG' IgM (Tago Inc., Burlingame, CA) at 4°C for 10-12 h. After incubation at room temperature for 1 h, the nonadherent cells were collected, washed, and incubated on ice with rat anti-mouse CD8 mAb (clone 53-6.7; ATCC), for 30 min. The cells were then washed and added to affinity-purified goat anti-rat IgG (Boehringer Mannheim Biochemicals)-coated petri dishes . 1 h later, the nonadherent cells were collected, washed, and resuspended in PBS.
After each panning procedure, the purified CD4' cells were stained with mAbs and analyzed using the FACS II in order to check the purity of the cells. After the panning procedure, the CD4' cells were enriched from a mean of 24.3% of the unfractionated spleen cells to a mean of 80.4% of the purified (panned) cells . The mean contamination of Ig' and CD8' cells was 5.3% and 3.2%, respectively.
DTH. 24 h after sublethal whole body irradiation (550 rad), BALB/c mice were injected intravenously with syngeneic spleen cells and intraperitoneally with TNP keyhole limpet hemocyanin (TNP-KLH ; 100 ug/mouse) . KLH (purchased from Calbiochem-Behring Corp., LaJolla, CA) was conjugated with TNP according to the method of Little and Eisen (33). 3 wk later, the immunized mice were injected subcutaneously in the left footpad with 30 pl of TNP-KLH (15 pg/mouse) in PBS and in the right footpad with the same volume of PBS . Footpad thickness was measured both before and at different time points after the injection by using a dial-gauge caliper (7312; Mitutoyo) . Footpad swelling is signified in the graph as the difference between the thickness of the experimental (TNP-KLH injected) and control (PBS injected) foot of each mouse. Data are presented in 10-3 cm.
Adoptive Cell Transfer Procedure. Adoptive hosts were given a single dose of whole body sublethal irradiation (550 rad). 24 later, graded numbers ofnonfractionated syngeneic spleen cells or CD4' cells plus IgG' cells from normal or TLI-treated mice were injected into the hosts' tail vein. At the same time, the mice were immunized intraperitoneally with TNP-KLH . Each injection contained 100 hg TNP-KLH diluted with PBS in a total volume of 250 p,l . The mice were bled from the retro-orbital veins both before immunization and at weekly intervals after immunization. The blood was allowed to clot at room temperature . Serum was separated by centrifugation and stored at -20°C for further testing .
Antibody Determination . Serum antibody to TNP was measured by the indirect ELISA as described previously (34) . Flat-bottomed microtiter plates (96-well ; Dynatech Laboratories, Inc., Alexandria, VA) were coated with TNP-BSA. Serial two-fold dilutions ofthe serum samples were added for 1 h at room temperature. The plates were washed and incubated at room temperature with 100 pl ofa 1 :3,000 dilution ofperoxidase-conjugated goat anti-mouse IgG (y and L chain specific, Tago Inc.). 1 h later, the plates were washed and 100,ul/well of substrate solution containing 15 pg/ml of2,2,azino-Di-(3-ethylbenzthiazoline) sulfonic acid (Sigma Chemical Co., St. Louis, MO) and 0.3 % H202 in citrate buffer (pH 4) were added. Antibody responses are represented in units, whereby, the number of units = (1/dilution of experimental serum [at a given OD])/(1/dilution of standard serum).
IgE-speck ELISA . The same reagents and techniques described by Coffman and Carty (18) were used. Briefly, polyvinyl chloride 96-well plates (Dynatech Laboratories, Inc.) were coated for 2 h with an anti-IgE mAb, EM 95, at a concentration of 4.0 Jig/ml . The nonspecific binding sites were blocked with PBS plus 20% FCS . The plates were washed with PBS plus 0.04% Tween 20. The standard sample and experimental serum were added to wells at graded concentrations in 100 pl. Then the plates were incubated overnight at 4°C . The plates were then washed again with PBS plus 0.04% Tween 20. The second-step antibody, nitroiodophenyl acetic acid-conjugated purified antiTNP-KLH, was added and incubated at room temperature for 4 h. An optimum concentration (1 :3,000) of horseradish peroxidase-conjugated anti-NIP mAb was added after the plates were washed yet again . 1 h later, the plates were washed and 100 Al/well substrate solution was added. The plates were read on an ELISA machine (Dynatech Laboratories, Inc.).
Graft vs. Host Disease (GVHD) Assay. 24 h after C57BL/Ka (H-2b) mice were lethally irradiated with a single dose of 850 rad, the recipients were injected intravenously with 2.5 x 106 allogeneic bone marrow (BM) cells obtained from the femurs and tibias of BALB/c (H-2d) mice. Graded numbers of purified spleen CD4* cells from either normal or TLI-treated BALB/c mice were injected intravenously together with BM cells . The control groups included lethally irradiated mice given no cells and mice injected with allogeneic BM cells alone. The mortality rate in all groups was recorded up to 100 d after cell transfer.
GVHD Suppression Assay. The experimental conditions were the same as those described above for the GVHD assay except that 2.5 x 106 putative suppressor cells (TLI CD4* cells) were coinjected into one group of the recipients with an equal number of normal CD4* cells and allogeneic BM cells. Mice that received CD4* and BM cells from either normal or TLI donors were part of the control groups . The mortality rate was recorded up to 100 d after cell transfer.
Establishment ofAlloreactive Clones . Cells specific for alloantigens were cloned directly from the spleens ofnormal or TLI-treated BALB/c mice by limiting dilution with irradiated CBA/J stimulator cells (2 x 105/well) (U-bottomed 96-well plate; Costar, Cambridge, MA) using the technique described previously by Mosmann et al. (12) . The clones were grown on alternate cycles ofalloantigen stimulation once every 2 wk, alternating with growth in the medium alone, which includes RMPI 1640, 10% FCS, 0.05 mM 2-ME, 50 Rg/ml gentamicin, and mouse rIL-2 (400-500 U/ml). Depending upon the density of cell growth in the wells, the cultured cells were expanded to another 96-well plate using the same medium .
Stimulation of CD4* Clones and Spleen Cells for Cytokine Secretion . Alloreactive clones were washed twice and resuspended in IL-2-free medium containing 5 Fig/ml Con A, (CalbiochemBehring Corp.). The supernatants were harvested 24 h later and analyzed using specific bioassays for the presence of IL-2 and IL-4 and in two-site sandwich ELISAs for the presence of IFN --y and IL-5. Spleen cells from normal or TLI-treated BALB/c mice (10 7/ml) were washed and resuspended in RPMI 1640 containing 10% FCS . These cells were stimulated with hamster anti-mouse T3 antibody (gift ofDr. J. Bluestone, University ofChicago) diluted to 1 :200, or Con A (5 kg/ml) plus PMA (10 ng/ml) . The stimulation supernatants were harvested 8 and 24 h later and assayed for cytokine secretion .
Cytokine Determinations of IL-2 and IL-4. Samples were assayed for IL-2 and IL-4 using the colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) (M2128; Sigma Chemical Co.) proliferation assays as described previously (35) . Briefly, IL-2 was assayed on HT-2 cells in the presence of 11b11 anti-IL-4 mAb, and IL-4 was assayed on HT-2 cells in the presence of S4B6 anti-IL-2 mAb . Additional controls included testing samples on HT-2 cells alone or in the presence of both anti-IL-2 and anti-IL-4 antibodies. 1 U is defined as the amount of factor in 100 Al that resulted in a signal in the MTT assay equal to 50% of maximum signal .
Cytokine Determinations of IFN-y and IL-5. Samples were assayed for IFN-'f and IL-5 using two-site sandwich ELISAs (13, 36) . Briefly, microtiter plates were coated with either mAb XMG 1.2 in PBS for IFN--y or mAb TRFK5 in PBS for IL-5. After incubation with test samples and murine rIFN-.y and IL-5 standards, the plates were washed and incubated with affinity-purified rabbit anti-mouse IFN-y for assaying IFN-'y or biotin-conjugated mAb TRFK2 for assaying IL-5. The plates were then washed and incubated with goat anti-rabbit/ horseradish peroxidase conjugate (The Jackson Laboratory) for testing IFN-'y, and streptavidin-conjugated horseradish peroxidase for testing IL-5. Cleavage ofthe substrate 2,2'-azinoDi (3-ethylbenzthiazoline sulfonic acid) (ABTS) was determined on a VMAX microplate reader (Molecular Services, Menlo Park, CA) .
Phenotyping of Alloreactive Clones . The surface antigen phenotype of the clones was determined by a cytotoxicity assay using anti-CD8 or anti-CD4 mAbs (Cedarlane Laboratories, Homby, Ontario, Canada) and complement (C'). Cytotoxicity was evaluated using the colorimetric MIT assay (35) . The percentage ofkilling was calculated as: 100 x [control wells (C'+ medium) -assay wells (C' + antibodies)]/control wells.
Statistical Analysis. Statistical analyses were performed by using student's t test (two tailed) .
Results
Comparison ofAdoptive Transfer ofSpleen Cellsfrom Normal and TLI-treatedMice: Antibody Production andDTHResponse in the Same Recipients. 24 h after being given a single dose of whole body irradiation (550 rad), BALE/c mice were given TNP-KLH intraperitoneally and graded doses of syngeneic unfractionated spleen cells intravenously from normal or TLI-treated mice. In all instances, spleen cells were obtained from TLI-treated mice 4-6 wk after completion of irradiation . Previous experiments have shown that the percentage of CD4+ cells in the spleen was approximately normal at this time point after TLI (Bass, H., and S. Strober, manuscript submitted for publication) . Serum was obtained before and at weekly intervals after cell transfer and immunization . 21 d after the primary immunization, host footpads were injected subcutaneously with TNP-KLH. Footpad swelling was measured before and at different time points after the local immunization . This experimental system assayed both the DTH reaction and antibody production in the same mouse. Fig. 1 shows the results of DTH footpad swelling. As expected, in mice receiving normal spleen cells, the swelling peaked at 24 h after local immunization and started to decrease after 30 h. The control mice that received no cells but had antigen injected into their footpads showed no specific swelling . The footpad swelling increased with increasing numbers of cells transferred (6 .25 x 10 6 to 10 1 cells) from normal mice . When 5 x 10 1 cells were transferred from TLI-treated mice, the response was less than that with 6.25 x 10 6 normal cells. Thus, the TLI cells were at least eight times less efficient than normal cells in causing footpad swelling in a DTH reaction . This pattern was observed in two similar experiments. Fig. 2 shows the serum anti TNP antibody response in the same groups of mice . The response peaked at days 14-21 after immunization . Background levels of antibody were seen in the control mice that did not receive cells. Again, the production of antiTNP antibody increased substantially in the groups of mice receiving between 6.25 x 10 6 and 101 normal spleen cells. However, it was found that the anti-TNP antibody response transferred by 5 x 10' TLI spleen cells was similar to that with the same dose of normal spleen cells. The difference between these two groups was not statistically significant (p 3 0.05). This pattern was observed in three other similar experiments. Augmentation ofAntigen-specific IgE Production by Normal Ig' Cells Using Normal and TLI Splenic CD4+ Cells. It has been shown in other studies that IFN-'Y and IL-4 regulate IgE antibody synthesis reciprocally ; while IL-4 enhances IgE production >100 times in LPS-stimulated B cell cultures, a small amount of IFN--y can completely inhibit such a response (18, 19) . The difference in IgE production is one of the most important functional differences between Thl and Th2 clones. Therefore, it was essential to determine the antigen-specific IgE levels in the serum samples collected from the mice receiving adoptive cell transfer as shown above. As shown in Table I , the pre-bleed group and the mice receiving only antigen, Ig' cells, or CD4' cells alone had minimal amounts of IgE antibody. The results also showed a clear dose-response curve when graded numbers of CD4' cells were added with a constant number of Ig' cells. The IgE antibody level in mice given CD4' and Ig' cells was higher on day 7 than day 14 or 21. CD4' cells from TLI mice were capable of helping normal Ig' cells to produce higher levels of specific IgE antibodies than the same number of CD4' cells from BALB/c control mice . The average percentage increase on day 7 in the IgE level using TLI vs. normal CD4' cells was 98% in the group given 5 x 105 , 101% in the group given 2 x 106 , and 62% in the group given 5 x 106 CD4' cells. These increases were significantly different for all groups (p 4 0.01) . Comparison of GVHD Mediated by Normal and TLI CD4+ Cells. 24 h after lethal whole body irradiation, C57BL/Ka (H-2 b) mice received an intravenous injection of 2 .5 x 106 normal BALB/c (H-2 d) BM cells and purified CD4' cells from either normal or TLI-treated mice . The clinical signs of GVHD and mortality rate of all groups were recorded up to 100 d after the cell transfer. Fig. 4 shows that there was a close correlation between the dose of transferred CD4' cells and the survival rate in both groups of mice . All six C57BL/Ka mice given allogeneic bone marrow alone survived >100 d. None of the irradiated mice without bone marrow cell transfer lived >14 d. When 2 .5 x 106 normal CD4' cells were injected, five of six mice died by 100 d after cell transfer. The same dose of TLI CD4' cells only resulted in one death within six mice. Similarly, 5 x 106 TLI CD4' cells caused a higher mortality rate (two of the six mice died) than 5 x 105 normal CD4' cells (one of six mice died) but a lower mortality rate than 106 normal CD4' cells (three of six mice died). From these results, the TLI CD4' cells were estimated to be about seven to eight times less effective in inducing lethal GVHD than the same dose ofCD4' cells from Effect ofAdding TLI CD4' Cells to Normal CD4' Cells in the GVHD Assay. To identify whether the reduced efficiency of TLI CD4' cells in inducing GVHD was due to suppressor cells that have been observed in the spleen after TLI (37-39), an experiment was done to test the ability of CD4' cells from TLI mice to suppress normal GVHD. 2.5 x 106 TLI BALB/c CD4' cells were injected intravenously into lethally irradiated C57BL/Ka mice in combination with 2.5 x 106 each of normal BALB/c BM cells and CD4' cells. The mortality rate is shown in Fig. 5 .
All mice that received irradiation without BM cells died within 2 wk. None of the irradiated mice given allogeneic BM cells died within 100 d. One ofthe six mice receiving TLI CD4' cells died 64 d after cell transfer; in comparison, all mice given the same number of normal CD4' cells survived <3 wk. When 2.5 x 106 TLI CD4' cells were coinjected with normal CD4' cells, the TLI CD4' cells failed to suppress the lethal GVHD. All six mice died rapidly after the two inocula of CD4' cells were coinjected . Thus, the high survival rate of mice injected with TLI CD4' cells was more likely due to the lack of GVHD-inducing cells rather than to the presence of suppressor cells in the cell inoculum.
Comparison ofCytokine Secretion by Normal and TLISpleen Cells. The results described above demonstrated that unfractionated or CD4' spleen cells from TLI-treated mice had a relatively normal ability to help B cells in the adoptive antiTNP antibody response, but had an impaired capacity to transfer DTH or to induce GVHD. Since IL-4 and IL-5 are important cytokines in augmenting the antibody responses of B cells, and IL-2 and IFN-y are considered more crucial for the function of cellmediated immunity, the levels of cytokine secretion of spleen cells from normal or TLI-treated BALB/c mice were analyzed .
Spleen cells (10'/ml) obtained from both normal and TLI-treated BALB/c mice (12 mice/group) were stimulated with either hamster anti-mouse T3 mAb or Con A plus PMA in vitro. Supernatants were harvested after 8 and 24 h and assayed for cytokine secretion. Table II shows the levels of four cytokines from the spleen cell supernatants 24 h after stimulation. Con A plus PMA, in general, gave a much stronger stimulation Alloantigen-specific clones from both normal and TLI mice were established by limiting dilution . The clones were stimulated with alternate cycles of irradiated allogeneic spleen cells followed by growth in a medium containing rIL-2. Some clones were lost in the early cycles of stimulation. After four stimulations over a period of 2 mo, most clones stabilized and secreted sufficient cytokines to be detected . Three cloning experiments have been carried out from the spleen cells of normal and TLI-treated mice .
10 clones obtained from normal BALB/c spleen cells in cloning experiment no . 1 were selected in a blind manner (Table III) . The quantitative results in different clones could not be compared, because the cell numbers in each harvested well differed at the time of the assay. 8 of the 10 clones had clear cytokine secretion patterns characteristic of either Thl (IL-2 and IFN-y detected without IL-4 and IL-5) or Th2 (IL-4 and IL-5 detected without IL-2 and IFN-y) clones . Clones 1 and 10 were considered mixed cytokine clones because they secreted cytokines characteristic of both Thl and Th2 cells. The surface phenotypes of these clones are also shown in Table  III . 9 of the 10 clones had at least 72% cell lysis with anti-CD4 antibody and complement. Clone numbers 7 and 8 had some degree (8 .5 and 15 .9%) of cell lysis with the anti-CD8 antibody.
Comparison of Thl vs. Th2 Clone Ratios in Spleen Cellsfrom Normal and TLI Mice. A summary of three cloning experiments is shown in Table IV. The cloning frequency for both normal and TLI-treated BALB/c mice was essentially equivalent (0 .42-1.15% for normal BALB/c mice ; 0.14-1.48% for mice 1 mo after TLI treatment; 0.83-0.95% for mice 3 mo after TLI treatment) . A minority of clones secreted only one of the two cytokines in a subset : IL-2 or IFN-y for Thl clones ; IL-4 or IL-5 for Th2 clones . These clones were still categorized as either Thl or Th2 in Tables IV and V, but could be more appropriately considered as Thl-or Th2-like clones . The ratios of Thl and Th2 clones in both normal and TLI-treated BALB/c mice are shown in Table V . In 73 clones obtained from normal BALB/c mice, there were more Thl than Th2 clones . However, in 113 clones established from the spleens of TLI mice 1 mo after irradiation, there were seven times more Th2 than Thl clones . In a similar experiment, there were 43 clones obtained from BALB/c mice 3 mo after TLI treatment. Previous studies have shown a normalization of the MLR at that time point (31 On the other hand, these CD4+ cells were seven to eight times less efficient than normal CD4+ cells in inducing lethal GVHD in irradiated C57BL/Ka mice. This result was not likely to be explained by the existence ofsuppressor cells in the spleen of TLI mice, since coinjection of TLI CD4+ spleen cells with normal CD4' spleen cells did not alter the GVHD-inducing capacity of the latter cells.
Experiments using two different polyclonal T cell stimulators, anti-T3 antibody and Con A plus PMA, further demonstrated that both IL-2 and IFN -'Y secretion in vitro were profoundly depressed in spleen cells obtained from TLI-treated mice. However, IL-4 and IL-5 secretion in vitro were close to normal . Since the biological activities of cytokines in stimulated cell supernatants have been shown to correlate fairly well with their mRNA levels (13), it is reasonable to expect that secreted cytokines of spleen cells from TLI mice could also reflect their level of transcription activity.
The above studies indicated that spleen cells obtained from mice 4-6 wk after TLI showed several characteristics that suggested a selective deficiency of Thl-like cell functions. The cells had a reduced ability to adoptively transfer 17TH and GVHD (cell-mediated immunity), and synthesized reduced amounts of IL-2 and IFN-y in response to polyclonal stimulation. In contrast, the Th2-like functions of TLI-derived CD4+ cells were similar to those of normal BALB/c mice. B cell helper function in an adoptive transfer system was normal, and the synthesis of IL-4 and IL-5 by spleen cells from TLI-treated mice was close to normal values .
Since these results were consistent with selective depletion of Thl-like cells from the spleen of TLI-treated mice, we attempted to directly determine whether there was a selective deficiency of precursor cells of Thl clones after TLI. Spleen cells from TLI and normal mice were stimulated in vitro with alloantigens, cloned by limiting dilution, and their cytokine secretion patterns were analyzed to identify Thl and Th2 clones. A total of 229 clones were established from spleen cells from both normal and TLI-treated BALB/c mice . Clones that secreted IL-2 or IFN-'y without IL-4 and IL-5 can be considered Thl-like, and those that secreted IL-4 or IL-5 without IL-2 and IFN-y can be considered Th2-like. Spleen cells from normal BALB/c mice generated more Thl and Th2 clones (ratio 1 :0.6). Spleen cells from TLI-treated mice generated a total of 113 clones with more Th2-than Thl-like clones, thus inverting the Thl/Th2 ratio to ti1 :7 .6. Furthermore, 3 mo after TLI, a time when the MLR recovers to normal levels (31), the ratio of Thl-to Th2-like clones (1 :1) was closer to that of normal mice .
The results with TLI mice can be explained by a selective decrease in the number of precursor or mature Thl as compared with Th2-like cells in the spleen 4-6 wk after TLI. Since most of the evidence showing normal Th2 but reduced Thl-like cell numbers and function was derived from cloning or adoptive transfer experiments, which would allow time for differentiation of precursor cells, it is likely that the differences observed in the TLI spleen are due to changes in the frequencies of Thl-like precursor cells. This deficiency may be due to an inability of the thymus of TLI-treated mice to produce or export T cells capable of differentiating into Thllike cells. Alternatively, the export of such cells may be normal, but post-thymus maturation of Thl-like cells may be selectively impaired .
It is of interest that all Thl-like functions were reduced after TLI, but Th2-like functions remained at normal levels, with the exception ofIgE secretion, which was somewhat elevated . This may be related to the ability of IFN-y (from Thl cells) to inhibit IL-4-induced IgE secretion, and the release ofthis inhibition in TLI mice .
Two lines of evidence suggest that there are other Th cell cytokine secretion patterns in addition to the prototypical Thl and Th2 patterns . First, the Pgp-1' subset of CD4' spleen cells secretes substantial levels of IL-2 but very little IFN-'r (40, 41) , and normal spleen cell populations often secrete IL-2 but little or no detectable IL-4 or IL-5 (42, 43) . These results are not consistent with the pattern expected if CD4+ spleen cell populations consisted only of prototypic Thl and Th2 cells. Further evidence for additional heterogeneity of Th cells was obtained in the present study, since there were 38 mixed cytokine clones in a total of 229 clones analyzed in the above experiments. This could be accounted for by multiple clones (Thl and Th2) coexisting in a single well. However, it was unlikely that these wells contained multiple clones because of the low frequency of positive wells. Many clones of mixed cytokine secretion phenotype have also been isolated in additional studies (Street, N., and T. Mosmann, unpublished results), and in some cases, the mixed pattern has remained stable on subcloning . These mixed cytokine clones might constitute another type of CD4+ cells that combines the cytokine secretion and functions of both Thl and Th2 cells. They may also represent different stages of the CD4+ cell differentiation pathway. Regardless ofthe extent of heterogeneity within the Th population, the present study shows that several immune functions are selectively and coordinately reduced in TLI mice, and all of these correspond to functions of in vitro Thl-like clones . Conversely, all functions predicted to be mediated by Th2-like cells are preserved. Thus, this study demonstrates a dichotomy of immune function in vivo that parallels the dichotomy of immune functions mediated by Thl and Th2 clones in vitro.
The previous studies of TLI mice showed a diminished primary antibody response, but a vigorous secondary antibody response to SRBC (44) . The primary antibody response to DNP-KLH in CFA was also decreased (45) . The current study shows a normal ability of TLI spleen cells to adoptively transfer the primary antibody response to TNP-KLH in aqueous solution, and appears inconsistent with the previous results. However, differences in activation of Thl-or Th2-like cells might be determined by the type of antigen or adjuvant used . In recent cloning experiments, it was found that some antigens appear to preferentially favor the activation and growth of certain clones . For example, CFA injected into mice favors the activation/differentiation of Thl cells (Street, N., and T. Mosmann, unpublished results) . Thus, in mice given TLI, antibody responses that depend heavily on Thl-like cells might be substantially reduced.
Several previous studies from patients given TLI support the current conclusions. Patients with Hodgkin's disease lost their 17TH skin reaction to dinitro-chlorobenzene for many months after radiation therapy (30) . In addition, purified CD4+ cells from TLI-treated patients had markedly reduced proliferative responses to alloantigens and mitogens in vitro (29) . However, the CD4+ cells can help the same patients' unirradiated B cells to produce normal levels of Ig in vitro in response to PWM (Field, E., and S. Strober, unpublished observations) . The incidence of severe bacterial infection among TLI patients was <1% (31) . In addition, there are no significant changes in total or specific IgE levels in patients after TLI (46) . Thus, the dichotomy of Th functional deficits observed in mice is consistent with the results in humans .
Summary
Purified CD4+ BALB/c spleen T cells obtained 4-6 wk after total lymphoid irradiation (TLI) helped normal syngeneic B cells to produce a vigorous antibody response to TNP keyhole limpet hemocyanin in adoptive cell transfer experiments. However, the same cells failed to transfer delayed-type hypersensitivity to the adoptive hosts as measured by a foot pad swelling assay. In addition, purified CD4' cells from TLI-treated mice were unable to induce graft vs. host disease in lethally irradiated allogeneic C57BL/Ka recipient mice. In response to mitogen stimulation, unfractionated spleen cells obtained from TLI mice secreted normal levels of IL-4 and IL-5, but markedly reduced levels of IL-2 and INFy . A total of 229 CD4' clones from spleen cells of both normal and TLI-treated mice were established, and the cytokine secretion pattern from each clone was analyzed . The results demonstrate that the ratio of Thl-and Th2-like clones in the spleens of normal BALB/c mice is 1 :0 .6, whereas the ratio in TLI mice is ti 1 :7 .
These results suggest that Th2-like cells recover rapidly (at N4-6 wk) after TLI treatment and account for the early return of antibody helper activity and secretion of IL-4 and IL-5, but Thl-like cells recover more slowly (in -3 mo) after irradiation, and this accounts for the deficit in cell-mediated immunity and the reduced amount of IL-2 and IFN-y secretion.
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